Brimonocond ®:Brimonidine tartrate 0.2%
Preservative: Benzalkonium Chloride
Brimonocond is an alpha adrenergic receptor agonist. It has a peak ocular hypotensive effect occurring at two hours post-dosing.
Brimonidine tartrate has a dual mechanism of action by
1- reducing aqueous humor production and
2- increasing uveoscleral outflow.
Brimonocondis indicated in open angel glaucoma
Dosages and administration:
One drop of Brimonocond (brimonidine tartrate) in the affected eye(s) three times daily, approximately 8 hours apart
Presentation:Bottle of 5 ml ophthalmic solution.